Explore more publications!

Keystone State Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Keystone State Herald.

Press releases published on January 9, 2026

Direct Online Marketing Launches Service To Help Brands Show Up In AI Search Engines Like ChatGPT
Philly's Big Soccer Year Starts Now with 50th Annual United Soccer Coaches Convention
Retired Urban Planner Richard G. Bickel Recently Featured on Close Up Radio
EACR Inc – Allentown Reaffirms Commitment to Compliant Solar Panel Recycling Services for Pennsylvania Businesses
Creative Repute Celebrates 9 Years Aligning Strategy, Design, and Automation
Liberty Pultrusions Introduces New UltraShield FRP Privacy and Security Wall Panels To Its Custom Pultrusion Products
CoreWeave, Inc. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages CoreWeave, Inc. (NASDAQ: CRWV) Investors with Significant Losses to Contact the Firm
First Commonwealth to Host Fourth Quarter and Full-Year 2025 Earnings Conference Call on Wednesday, January 28, 2026
Choice Granite and Marble in Pittsburgh Announces Major Showroom Expansion and Launch of New Premium Cabinet Collection
First Federal Data Breach Claims Investigated by Lynch Carpenter
Toll Brothers Announces the Release of New Ranch Home Designs at Aurora Ridge at Great Sky in Canton, Georgia
First Federal Data Breach Claims Investigated by Lynch Carpenter
Children’s Book 'THE FAIRY AND THE FROG' Brings Young Readers a Heartfelt Journey of Courage, Curiosity, and Friendship
Deadline Approaching: Klarna Group plc (KLAR) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
DYWIDAG completes sale of TAM Groupe to Private Assets as planned
Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39
Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor
Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions